Epileptika aims to help treat refractory epilepsy in people with intellectual disability

FHS
July 26, 2023
5:28 pm

A team of researchers from the Universitat Politècnica de València (UPV) has participated in the development of Epileptika.

Cetuximab biobetter by Shanghai Henlius Biotech for Recurrent Head And Neck Squamous Cell Carcinoma: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

December 5, 2023

Ionis blazed trails in genetic medicine. On the cusp of a major approval, can it also be a commercial success?

CARLSBAD, Calif. — Stroll inside Ionis Pharmaceuticals’ Southern California headquarters, past the giant hanging glass sculpture of an RNA molecule, and you can’t miss it

December 13, 2024

ICER casts doubt on Sarepta’s DMD gene therapy

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning! A crowdsourced

May 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.